These results indicated that 919 syrup could reverse the abnormal expression Ghrelin pathway-related genes in the brain and stomach of rats with NAFLD, and that the decrease in body weight and feed intake observed in treated rats might be related to regulation of Npy/Agrp. The gene discussed is NPY; the disease is metabolic dysfunction-associated steatotic liver disease.